Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65551 - 65575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	PTCH1	5727	upregulated	resveratrol results in increased expression of PTCH1 mRNA	9q22.32	A23876
Resveratrol	Investigational	PTEN	5728	upregulated	[resveratrol results in decreased activity of AR protein] which results in increased expression of PTEN mRNA	10q23.31	A20146
Resveratrol	Investigational	PTEN	5728	downregulated	resveratrol results in decreased expression of PTEN mRNA	10q23.31	A23878
Resveratrol	Investigational	PTEN	5728	upregulated	resveratrol results in increased expression of PTEN mRNA	10q23.31	A22790 A21623 A22435
Resveratrol	Investigational	PTGER1	5731	downregulated	resveratrol results in decreased expression of PTGER1 mRNA	19p13.1	A21627
Resveratrol	Investigational	PTGES	9536	upregulated	resveratrol results in increased expression of PTGES mRNA	9q34.11	A23852
Resveratrol	Investigational	PTGS1	5742	downregulated	resveratrol results in decreased expression of PTGS1 mRNA	9q33.2	A21819
Resveratrol	Investigational	PTGS2	5743	downregulated	resveratrol results in decreased expression of PTGS2 mRNA	1q31.1	A22791 A23873 A20459 A22435 A24002
Resveratrol	Investigational	PTGS2	5743	upregulated	resveratrol results in increased expression of PTGS2 mRNA	1q31.1	A23894 A24003 A24004 A23845
Resveratrol	Investigational	PTK2	5747	downregulated	resveratrol results in decreased expression of PTK2 mRNA	8q24.3	A23858
Resveratrol	Investigational	PTPN11	5781	upregulated	resveratrol results in increased expression of PTPN11 mRNA	12q24.13	A24005
Resveratrol	Investigational	PTPRA	5786	downregulated	resveratrol results in decreased expression of PTPRA mRNA	20p13	A23847
Resveratrol	Investigational	PTPRE	5791	upregulated	resveratrol results in increased expression of PTPRE mRNA	10q26.2	A24005
Resveratrol	Investigational	PTPRG	5793	downregulated	resveratrol results in decreased expression of PTPRG mRNA	3p14.2	A23902
Resveratrol	Investigational	PTPRN2	5799	upregulated	resveratrol results in increased expression of PTPRN2 mRNA	7q36.3	A23847
Resveratrol	Investigational	PTTG1	9232	upregulated	resveratrol results in increased expression of PTTG1 mRNA	5q33.3	A21103
Resveratrol	Investigational	PYROXD2	84795	upregulated	resveratrol results in increased expression of PYROXD2 mRNA	10q24.2	A23852
Resveratrol	Investigational	RABGAP1L	9910	downregulated	resveratrol results in decreased expression of RABGAP1L mRNA	1q25.1	A23852
Resveratrol	Investigational	RAC3	5881	downregulated	resveratrol results in decreased expression of RAC3 mRNA	17q25.3	A23905
Resveratrol	Investigational	RACGAP1	29127	upregulated	resveratrol results in increased expression of RACGAP1 mRNA	12q13.12	A21103
Resveratrol	Investigational	RAD51	5888	upregulated	resveratrol results in increased expression of RAD51 mRNA	15q15.1	A23885
Resveratrol	Investigational	RAD51AP1	10635	downregulated	resveratrol results in decreased expression of RAD51AP1 mRNA	12p13.32	A23857
Resveratrol	Investigational	RAD9B	144715	downregulated	resveratrol results in decreased expression of RAD9B mRNA	12q24.11	A23856
Resveratrol	Investigational	RAN	5901	downregulated	resveratrol results in decreased expression of RAN mRNA	12q24.33	A22498 A23847
Resveratrol	Investigational	RARA	5914	upregulated	resveratrol results in increased expression of RARA mRNA	17q21.2	A21627

Displaying entries 65551 - 65575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability